Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Przemysław Kotyla's publication output changed over time?
ScholarIQpublication output · 2012–2022
Output grew100% over the shown period — from 1 works in 2012 to 2 in 2022.
1
2
2
3
1
2
201220182019202020212022
What are the most-cited papers on Przemysław Kotyla?
ScholarIQmost cited works
Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis
Md Asiful Islam, Shahad Saif Khandker, Sayeda Sadia Alam, Przemysław Kotyla, Rosline Hassan
Autoimmunity Reviews. 2019129 Citations
Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
Md Asiful Islam, Shahad Saif Khandker, Przemysław Kotyla, Rosline Hassan
Frontiers in Immunology. 2020122 CitationsOPEN ACCESS
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
Przemysław Kotyla, Małgorzata Engelmann, Joanna Giemza-Stokłosa, Bartosz Wnuk, Md Asiful Islam
International Journal of Molecular Sciences. 202167 CitationsOPEN ACCESS
Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide
Przemysław Kotyla, Aleksander Owczarek, Jarosław Rakoczy, Maciej Lewicki, EUGENE J. KUCHARZ, Paul Emery
The Journal of Rheumatology. 201259 CitationsOPEN ACCESS
Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
Przemysław Kotyla, Md Asiful Islam, Małgorzata Engelmann
International Journal of Molecular Sciences. 202050 CitationsOPEN ACCESS
Related on ScholarIQ
Medical University of Silesia
Institution
Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis
Paper
Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
Paper
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
Paper
Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide
Paper
Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
Paper